1-hour postprandial insulin
1 paper
- Human trial1
Latest
The American Journal of Medicine
Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study
Randomised trial in 94 peopleMetformin